Can heart patients take deflazacort?
For these reasons, before you start taking deflazacort it is important that your doctor knows: If you have high blood pressure. If you have had a heart attack, or if you have any other heart problems. If you have any problems with the way your liver works, or if you have any problems with the way your kidneys work.
What is the indication of deflazacort?
Deflazacort is used to treat Duchenne muscular dystrophy (DMD; a progressive disease in which the muscles do not function properly) in adults and children 2 years of age and older. Deflazacort is in a class of medications called corticosteroids.
What is the action of deflazacort?
Mechanism Of Action Deflazacort is a corticosteroid prodrug, whose active metabolite, 21-desDFZ, acts through the glucocorticoid receptor to exert anti-inflammatory and immunosuppressive effects. The precise mechanism by which deflazacort exerts its therapeutic effects in patients with DMD is unknown.
Is deflazacort a safe steroid?
This medicine may cause thinning of the bones (osteoporosis), loss of blood supply, or slow growth in children if used for a long time. Tell your doctor if you have any bone or joint pain or if you have an increased risk for osteoporosis.
What are side effects of deflazacort?
Side effects of Deflazacort include:
- Cushingoid appearance.
- Weight gain.
- Increased appetite.
- Upper respiratory tract infection.
- Cough.
- Urinary frequency.
Is deflazacort safer than prednisolone?
As learnt from the available literature, it can be stated that deflazacort has no advantages over prednisolone in short-term use; further, on the basis of current evidence provided in present studies, it is not possible to confirm whether the trend shown in trials of lower risk in long-term side effects will be borne …
Which is better prednisolone or deflazacort?
In general, deflazacort appears to have less effect than prednisone on parameters that may be associated with the development of corticosteroid-induced osteoporosis. Further, the drug appears have less negative impact on growth rate in children with diseases requiring corticosteroid therapy.